These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 37582114

  • 21. Interchangeability of Quinvaxem during primary vaccination schedules: results from a phase IV, single-blind, randomized, controlled, single-center, non-inferiority study.
    Capeding MR, Jica C, Macura-Biegun A, Rauscher M, Alberto E.
    Vaccine; 2014 Feb 07; 32(7):888-94. PubMed ID: 24176498
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Antibody persistence of two pentavalent DTwP-HB-Hib vaccines to the age of 15-18 months, and response to the booster dose of quadrivalent DTwP-Hib vaccine.
    Sharma H, Yadav S, Lalwani S, Kapre S, Jadhav S, Parekh S, Palkar S, Ravetkar S, Bahl S, Kumar R, Shewale S.
    Vaccine; 2013 Jan 07; 31(3):444-7. PubMed ID: 23196204
    [Abstract] [Full Text] [Related]

  • 24. Safety and immunogenicity of a new fully liquid DTPw-HepB-Hib combination vaccine in infants.
    Kanra G, Kara A, Demiralp O, Contorni M, Hilbert AK, Spyr C, Viviani S.
    Hum Vaccin; 2006 Jan 07; 2(4):155-60. PubMed ID: 17012890
    [Abstract] [Full Text] [Related]

  • 25. Safety and immunogenicity of a hexavalent vaccine administered at 2, 4 and 6 months of age with or without a heptavalent pneumococcal conjugate vaccine: a randomized, open-label study.
    Tapiéro B, Halperin SA, Dionne M, Meekison W, Diaz-Mitoma F, Zickler P, Rubin E, Embree J, Bhuyan P, Lee AW, Li M, Tomovici A.
    Pediatr Infect Dis J; 2013 Jan 07; 32(1):54-61. PubMed ID: 23241989
    [Abstract] [Full Text] [Related]

  • 26. Immunogenicity and reactogenicity of a combined fully liquid DTPw-HepB-Hib pentavalent vaccine in healthy infants: no clinically relevant impact of a birth dose of hepatitis B vaccine.
    Gentile A, Umido V, Czerniuk P, Nacul J, Seigelchifer M, Hilbert AK, Yela U, Herzog C, Aeberhard U, Spyr C.
    Int J Infect Dis; 2011 Jan 07; 15(1):e24-9. PubMed ID: 21093342
    [Abstract] [Full Text] [Related]

  • 27. Safety and immunogenicity of two formulations of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae conjugate-hepatitis B vaccine in 15 to 18-month-old children.
    Halperin SA, Langley JM, Hesley TM, Zappacosta PS, Radley D, Smith B, Hoffenbach A, Boslego J, Silber JL.
    Hum Vaccin; 2005 Jan 07; 1(6):245-50. PubMed ID: 17012871
    [Abstract] [Full Text] [Related]

  • 28. A randomized, controlled trial to assess the immunogenicity and safety of a heptavalent diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, hib and meningococcal serogroup C combination vaccine administered at 2, 3, 4 and 12-18 months of age.
    Szenborn L, Czajka H, Brzostek J, Konior R, Caubet M, Ulianov L, Leyssen M.
    Pediatr Infect Dis J; 2013 Jul 07; 32(7):777-85. PubMed ID: 23838777
    [Abstract] [Full Text] [Related]

  • 29. A randomized, open-label clinical trial to evaluate immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Easyfour®-TT) with Quadrovax® in Indian infants.
    Mohanty L, Sharma S, Behera B, Panwar S, Paliwal C, Singh A, Gupta A, Chilkoti DC.
    Hum Vaccin Immunother; 2017 Sep 02; 13(9):2025-2031. PubMed ID: 28700282
    [Abstract] [Full Text] [Related]

  • 30. A randomized study to evaluate the immunogenicity and safety of a heptavalent diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, haemophilus influenzae b, and meningococcal serogroup C combination vaccine administered to infants at 2, 4 and 12 months of age.
    Thollot F, Scheifele D, Pankow-Culot H, Cheuvart B, Leyssen M, Ulianov L, Miller JM.
    Pediatr Infect Dis J; 2014 Dec 02; 33(12):1246-54. PubMed ID: 25037033
    [Abstract] [Full Text] [Related]

  • 31. A multicenter, prospective, open-label, non-comparative study to evaluate the immunogenicity and tolerance of a new, fully liquid pentavalent vaccine (DTwP-HepB-Hib vaccine).
    Ali SS, Chandrashekar SR, Singh M, Bansal RK, Sharma DR, Arora D.
    Hum Vaccin; 2007 Dec 02; 3(4):116-20. PubMed ID: 17617743
    [Abstract] [Full Text] [Related]

  • 32. A new DTPw-HBV/Hib vaccine is immunogenic and safe when administered according to the EPI (Expanded Programme for Immunization) schedule and following hepatitis B vaccination at birth.
    Gatchalian S, Reyes M, Bernal N, Lefevre I, David MP, Han HH, Bock HL, Wolter J, Schuerman L.
    Hum Vaccin; 2005 Dec 02; 1(5):198-203. PubMed ID: 17012860
    [Abstract] [Full Text] [Related]

  • 33. Live attenuated tetravalent (G1-G4) bovine-human reassortant rotavirus vaccine (BRV-TV): Randomized, controlled phase III study in Indian infants.
    Saluja T, Palkar S, Misra P, Gupta M, Venugopal P, Sood AK, Dhati RM, Shetty A, Dhaded SM, Agarkhedkar S, Choudhury A, Kumar R, Balasubramanian S, Babji S, Adhikary L, Dupuy M, Chadha SM, Desai F, Kukian D, Patnaik BN, Dhingra MS.
    Vaccine; 2017 Jun 16; 35(28):3575-3581. PubMed ID: 28536027
    [Abstract] [Full Text] [Related]

  • 34. Immunogenicity, Safety, and Tolerability of a Hexavalent Vaccine in Infants.
    Marshall GS, Adams GL, Leonardi ML, Petrecz M, Flores SA, Ngai AL, Xu J, Liu G, Stek JE, Foglia G, Lee AW.
    Pediatrics; 2015 Aug 16; 136(2):e323-32. PubMed ID: 26216331
    [Abstract] [Full Text] [Related]

  • 35. Immunogenicity of a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine when mixed with a diphtheria-tetanus-acellular pertussis-hepatitis B combination vaccine.
    Greenberg DP, Wong VK, Partridge S, Chang SJ, Jing J, Howe BJ, Ward JI.
    Pediatr Infect Dis J; 2000 Dec 16; 19(12):1135-40. PubMed ID: 11144372
    [Abstract] [Full Text] [Related]

  • 36. The effect of reconstitution of an Haemophilus influenzae type b-tentanus toxoid conjugate (PRP-T) vaccine on the immune responses to a diphtheria-tetanus-whole cell pertussis (DTwP) vaccine: a five-year follow-up.
    Hoppenbrouwers K, Roelants M, Ethevenaux C, Vandermeulen C, Knops J, Desmyter J.
    Vaccine; 1999 Jun 04; 17(20-21):2588-98. PubMed ID: 10418907
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants.
    Lee CY, Thipphawong J, Huang LM, Lee PI, Chiu HH, Lin W, Debois H, Harrison D, Xie F, Barreto L.
    Pediatrics; 1999 Jan 04; 103(1):25-30. PubMed ID: 9917435
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.